Stablepharma
PrivateLast Round
Grant
Feb 19, 2025
Est. Valuation
$50.25M
Total Funding Raised
$12.31M
Company Overview
Stablepharma is a biotechnology company that develops a technology platform to transform approved vaccines, therapeutics, and diagnostics into thermostable products, ensuring safe and efficient delivery while minimizing waste and carbon emissions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stablepharma Comparables
Compare Stablepharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VitriVax, Inc. | 87% | |
| Inaedis Inc. | 84% | |
| EnsiliTech | 83% | |
Stablepharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 19, 2025 | ||||
| Crowdfunding | Jun 14, 2024 | ||||
| VC Round | Oct 23, 2023 | ||||
| Grant | Sep 12, 2023 | ||||
| Series A | Dec 23, 2022 | ||||
Crowdfunding | Aug 5, 2021 |
Key People
Founding team and executive leadership
Stablepharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Crowdcube Investors | Crowdfunding, VC Round, Series A, Seed |
| European Innovation Council Fund | Grant |
| Ascension Ventures | Series A |
| Innovate UK | Grant |
| Oval Investments Limited | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2026
SPVX02 targets tetanus and diphtheria, developed with UKHSA support.
- Jan 15, 2026
Developing fridge-free sterile injectable medicines with AFT Pharmaceuticals.
Stablepharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stablepharma's valuation, stock price, and market status.